INEXIUM

ASTRAZENECA
Identification
- Active ingredient (INN)
- ESOMEPRAZOLE
- Internal code
- 10 A 222
- Country of Origin
- Algeria
- Pharmaceutical form
- Gastro-resistant Tablet
- Prescription List
- Regulated (List II)
- Packaging
- b/14

DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
is indicated for the short-term treatment of symptoms of gastroesophageal reflux (e.g. pyrosis and acid regurgitation) in adults.
Associated Conditions
If patients are advised to take a reduced dose of the drug, the drug is not a good or bad.
If patients are not able to take a reduced dose of the drug, the drug is not a good or bad.
If patients are not able to take a reduced dose of the drug, the drug is not a good or bad drug.
Mechanism of Action
Pharmacotherapeutic class
Medicinal product for acidity disorders, proton pump inhibitor, ATC code: A02BC05.
Esomeprazole is the
S-isomer of omeprazole and reduces acid gastric secretion by a specifically targeted mechanism of action.
It is a specific proton pump inhibitor at the parietal cell level.
Both R and
S isomers of omeprazole have similar pharmacodynamic activity.
Mechanism of action
Esomeprazole is a weak base.
It is concentrated and converted into an active form in the acidic environment of the parietal ducticles, where it inhibits the enzyme H+K+-ATPase (proton pump), the recombinant recitation of the underlying acid and the recitation of the recombinant acid, the recombinant recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombinant acid, the recombising acid.
Adverse Effects
Headache, abdominal pain, diarrhoea and nausea are among the most frequently reported adverse reactions in clinical studies (and also in post-marketing use).
Furthermore, the safety profile of use is similar for the different formulations, treatment indications, age groups and patient populations.
No dose-related adverse reactions were identified.
Tabulated summary of adverse reactions
The following adverse reactions were reported or suspected in clinical studies of esomeprazole and since its placing on the market.
Adverse reactions are classified by frequency according to the MedDRA convention: very common (≥ 1/10); common (≥ 1/100; <1/10); uncommon (≥ 1/1 000 to < 1/100); low (≥ 1/1 000 to < 1/100); low (≥ 1/1 000 to < 1/100); low (≥ 1/1 000 to < 1/100); low (≥ 1/10 000 to < 1/10); low (≥ 1/10); low (≥ 1/10 000 to < 1/100); low (≥ 1/10 000 to < 1/10); low (≥ 1/10 000); low (≥ 1/10 000 to < 1/1 000); low (≥ 1/1 000; low ( < 1/1 000); low (.
Warnings
Allergy alert
Do not use if you are allergic to esomeprazole.
Esomeprazole may cause severe skin reactions.
Symptoms may include: skin reddening blisters rash If an allergic reaction occurs, stop use and seek medical help right away.
Dosage & Administration
Directions adults 18 years of age and older this product is to be used once a day (every 24 hours), every day for 14 days may take to 4 days for full effect 14-Day Course of Treatment.
- swallow 1 tablet with a glass of water before eating in the morning.
- take every day for 14 days.
- do not take more than 1 tablet a day.
- swallow whole.
Do not crush or chew capsules.
- do not use for more than 14 days unless directed by your doctor Repeated 14-Day Courses (if needed).
- you may repeat a 14-day course every 4 months.
- do not take for more than 14 days or more often than every 4 months unless directed by a doctor children under 18 years of age: ask a doctor before use.
Heartburn in children may sometimes be caused by a serious condition.